Troponin I from fast skeletal and cardiac muscles can be phosphorylated at specific sites by 3':5'-cyclic AMP-dependent protein kinase and phosphorylase kinase (for review see Perry, 1979) . In the case of troponin I from fast skeletal muscle the role of the process in functioning tissue is unknown. Some phosphorylation presumably occurs in vivo, for, when isolated by affinity chromatography under conditions in which enzymic activity is not expected to occur, troponin I from skeletal muscle contains 0.4-0.5 mol of phosphate/mol (Cole & Perry, 1975) . The covalent bound phosphate of troponin I in skeletal muscle, however, does not apparently exchange readily with the intracellular pools of ATP, for Ribolow et al. (1977) could find no incorporation of phosphate into this protein during tetanus in frog gastrocnemius and semitendinosus muscles. From studies in vitro (Perry & Cole, 1974; Cole & Perry, 1975 ) the phosphorylation sites of skeletalmuscle troponin I would be expected to be blocked in the complex due to the presence of troponin C.
The situation with the phosphorylation of cardiac troponin I is clearly different. When isolated from rabbit hearts by affinity chromatography it contains much more covalently bound phosphate than troponin I isolated from fast skeletal muscle by the same procedure, usually ranging in amount from 1 to 2mol of phosphate/mol (Cole & Perry, 1975; . Likewise, the cardiac-muscle protein is much more rapidly phosphorylated by Vol. 185 3': 5'-cyclic AMP-dependent protein kinase, a process that is not significantly blocked by troponin C (Cole & Perry, 1975 ; . Rabbit cardiac-muscle troponin I contains an N-terminal sequence of 26 residues that is not present in the skeletal-muscle protein (Wilkinson & Grand, 1978) and which contains a serine residue at position 20 that is readily phosphorylated by 3': 5'-cyclic AMPdependent protein kinase in vitro . Rapid phosphorylation of this residue is responsible for the much higher rate of phosphorylation catalysed by the 3': 5'-cyclic AMP-dependent protein kinase of cardiac-muscle troponin I compared with the skeletal-muscle protein. Phosphorylation at serine-146 of cardiac-muscle troponin I is also catalysed by the 3':5'-cyclic AMP-dependent protein kinase. This would be expected, for the residue occurs in an analogous position in the molecule to serine-117 of troponin I from fast skeletal muscle that is the preferred site of phosphorylation by this enzyme .
The evidence that the extent of phosphorylation of troponin I increased when the perfused mammalian heart was treated with adrenaline (England, 1975; Solaro et al., 1976) strongly suggested that the phosphorylation of troponin I had a specific role in intact cardiac muscle. We have therefore investigated the sites of phosphorylation of troponin I in the rabbit heart perfused by the Langendorff procedure to compare them with those identified by studies in vitro . It has been shown that serine-20 is partially phosphorylated in the normal beating rabbit heart and that the phosphate moiety attached to this serine residue is virtually the only phosphate group that exchanges with the intracellular phosphate pool. On intervention with adrenaline all of the increase in the covalent phosphate content of cardiac-muscle troponin I is accounted for by further phosphorylation of serine-20. G-25, G-50 and G-75 Hearts were removed rapidly from stunned rabbits and after washing for 15-30s in ice-cold saline (0.9% NaCI) were perfused by the Langendorff procedure (Morgan et al., 1961) at 370C with a modified Krebs-Henseleit buffer containing 118 mM-NaCI/4.7 mM-KCI/ 1.2 mM-MgSO4/0.2 mm-KH2PO4/25 mM-NaHCO3/2.5 mM-CaCl2/0.5 mM-disodium EDTA/5 mM-glucose (Krebs & Henseleit, 1932) . Any alterations to this medium were made by the addition of stock solutions and resulted in dilution of the perfusate by less than 1.0%. The force and rate of contraction were recorded on a polygraph (George Washington, Sheerness, Kent, U.K.) with a force transducer [UFI Dynamometer; range 2oz (56.7g)] attached to a stainless-steel hook inserted into the apex of the heart. After an initial period (2-5 min) the force and rate became regular and remained virtually constant for up to 100min. Hearts were usually perfused after the initial period for a further 15min for equilibration before additions were made to the perfusate.
Materials and Methods

Sephadex
For experiments on the incorporation of 32p the initial 15 min equilibration was performed in the normal buffer and buffer containing 32p (10uCi/ml) as sodium orthophosphate was then introduced into the apparatus. Perfusion was usually carried out for a further 15 min before the isolation of 32P-labelled troponin I both in control experiments and after adrenaline treatment. When required, adrenaline was then added to the perfusion medium to a final concentration of 4,pM and perfusion was continued until the increase in the force of contraction was maximal (approx. 30s after addition of adrenaline). Hearts perfused with adrenaline were cut down at the peak of the force change and homogenized within 10-15s in a small Waring blender-type homogenizer with 40-50ml of solution containing 9 M-urea/75 mM-Tris/ 15 mMmercaptoethanol/1 mM-CaCl2, brought to pH 8.0 with 11.4M-HCl. Control hearts were treated in the same manner except that the short perfusion in the presence of adrenaline was omitted.
Isolation oftroponin I
Troponin I was isolated immediately from the urea extracts of perfused hearts by affinity chromatography using rabbit skeletal-muscle troponin C bound to Sepharose 4B (Syska et al., 1974) . The urea concentration was maintained at 9M throughout the isolation procedure to ensure that enzymes capable of the phosphorylation or dephosphorylation of troponin I were inactivated. Urea was removed from the purified troponin I by dialysis against 1 mM-NH4HCO3 (3 x 200vol.) or by gel filtration on columns of Sephadex G-25 or G-50 equilibrated and eluted with 0.01 M-HCl. Purity was determined by electrophoresis in 0.1% sodium dodecyl sulphate/0.01 M-sodium phosphate buffer (pH 7.0) (Weber & Osborn, 1969) .
Determination ofphosphate and nitrogen contents of troponin I samples Protein was estimated by Nesslerization (Strauch, 1965 ) assuming a mol.wt. of 23 500 derived from the amino acid sequence of rabbit cardiac-muscle troponin I (Grand et al., 1976) . Phosphate was determined by the method of Bartlett (1959) with lOM-H2SO4 (0.5 ml) for digestion; after reaction of the acid hydrolysate with aminonaphthol sulphonic acid reducer and ammonium molybdate, the final volume was made up to 5.0 ml.
Identification of the phosphorylated residues of cardiac-muscle troponin I Cardiac-muscle troponin I (100-300,ug) isolated from control and adrenaline-stimulated hearts that had been perfused in the presence of 32p were hydrolysed in vacuo at 110°C in 5.7M-HCl (0.5ml) for 1.5-3 h. After drying in vacuo the hydrolysates were applied to Whatman no. 1 paper (57cm x 20 cm) and subjected to electrophoresis at 3kV for 2-3 h at pH 2.0 (Wilkinson, 1974) in the presence of authentic samples of phosphoserine, phosphothreonine and [32p]p . The sheets were dried, stained with ninhydrin and 32P-containing material was located by radioautography.
Identification ofphosphorylatedpeptides
Cardiac-muscle troponin I (5-25 mg) labelled with 32P after perfusion under the appropriate conditions was digested with trypsin, thermolysin, pepsin or CNBr, the latter being performed in 0.1 M-HCI to minimize hydrolysis of phosphopeptides. Peptides containing 32p were purified by gel filtration, paper electrophoresis and paper chromatography and were detected by radioautography. The methods employed have been described in detail elsewhere .
Amino acid analysis 32P-containing peptides were hydrolysed in vacuo for 20h in 5.7 M-HCl at 1 100C. Amino acid analysis was performed on a Locarte amino acid analyser (Wilkinson et al., 1972) . No corrections were made for the loss of serine.
Results
Phosphate content of troponin I isolated from perfused rabbit hearts
The phosphate content of troponin I prepared by affinity chromatography from rabbit hearts perfused for 15 min with modified Krebs-Henseleit buffer was 1.14 + 0.20 mol of phosphate/mol (five preparations). If adrenaline (4puM) was included in the perfusion medium, the phosphate content of the troponin I at the peak of the force response increased to 1.86 + 0.50mol/mol (five preparations). These values are consistent with those routinely obtained in this laboratory for rabbit hearts perfused in the presence or absence of adrenaline. The values for the phosphate content of cardiac-muscle troponin I reported in the present study are significantly lower than those reported previously from this laboratory (Solaro et al., 1976) . In the previous study the phosphate values were consistently higher because of the slight differences in the H2SO4 concentration in the solution used for colour development for experimental determinations and for calibration of the colour response. This was due to significant loss of H2SO4 during the wet ashing procedure in the presence of relatively large amounts of organic material. The method as described in the Materials and Methods section is not subject to this error (C. M. Jones, R. J. Solaro & S. V. Perry, unpublished work). When 32P-labelled sodium orthophosphate was included in the perfusion medium, radioactivity was incorporated into the troponin I ( Table 1) , indicating that the protein-bound phosphate was exchanging with the intracellular phosphate pool.
If hearts perfused with 32P-labelled phosphate were subsequently treated with adrenaline (4pM) and the troponin I isolated at the peak of the resulting force increase, the amount of covalently bound 32p increased 4-5 times compared with the value in control hearts that had not been treated with adrenaline (Table 1) .
When troponin I was isolated from control and adrenaline-treated hearts perfused with 32P-labelled phosphate and subsequently hydrolysed in 5.7M-HCI for approx. 2h, radioactivity was found to be associated with phosphoserine separated by electrophoresis at pH2.0 (see the Materials and Methods section). No detectable amounts of radioactivity were associated with phosphothreonine in these digests and no phosphothreonine could be observed by staining with ninhydrin ( Fig. 1) .
Distribution of phosphate in the CNBr peptides of troponin Ifrom perfused hearts
Previous studies (Grand et al., 1976; have shown that when rabbit cardiacmuscle troponin I is completely digested with CNBr, free homoserine and four peptides designated peptide CCN3 (residues 1-48), peptide CCN2 (residues 49-150), peptide CCN4 (residues 152-197) and peptide CCN5 (residues 198-206) are obtained. These peptides are arranged in the troponin I molecule as illustrated in Fig. 2 .
The gel-filtration elution pattern of a CNBr digest of troponin I from a control heart applied to a column of Sephadex G-75 equilibrated and eluted with 0.01 M-HCI is illustrated in Fig. 3(a) . A similar elu- Some phosphate was found in a fraction containing the larger partial-digestion products that were eluted in a peak that was virtually unretarded on gel filtration and which was somewhat variable in amount between digests (cf. Figs. 3a and 3b) . Most of the phosphate was present in peak A, which consisted of a partial-digestion product represented by a peptide that contained residues 1-150 and in peak C 1, which contained the N-terminal peptide CCN3. Little phosphate was found in peptides containing residues 49-150 (peak B) or residues 152-197 (peak C2). A more complete separation of the two peptides present in peak C could be achieved by re-chromatography of this material on Sephadex G-50 ; this confirmed that phosphate was bound to the fragment containing residues 1-48 rather than the other component in peak C, the peptide containing residues 152-197. A similar distribution of phosphate was obtained if the CNBr peptides from troponin I isolated from adrenalinetreated hearts were fractionated in the same manner. The distribution illustrated in Fig. 3(b) Fig. 4(a) is typical of the results obtained in four different experiments. A similar distribution was obtained when the troponin I was prepared from muscle at the peak of response to adrenaline (Fig.   4b ). In the latter case, however, the amount of 32p in- (Grand et al., 1976) and the phosphorylation sites specific for 3': 5'-cyclic AMP-dependent protein kinase Numbers are residue positions in the sequence. Abbreviations used: N, N-terminus; C, C-terminus (from . corporated into peptide CCN3 in three different experiments ranged from five to seven times greater per mole than was the case with the control muscles. Identification of amino acid residues that are phosphorylated in the perfused heart 32P-labelled troponin I isolated from rabbit hearts perfused with Krebs-Henseleit buffer containing "2p was digested by using a mixture of trypsin and thermolysin (1: 1, by weight) in 50mM-NH4HCO3 and the digest was fractionated by gel filtration on a column (2.5 cm x 1 10cm) of Sephadex G-25, equilibrated and eluted with 50mM-NH4HCO3. All of the radioactivity was located in a single peak (Fig. 5) and the 32P-labelled peptides were separated by electrophoresis at pH6.5 of the fraction containing radioactive material followed by descending chromatography in n-butanol/acetic acid/water/pyridine (15:3:12:10, by vol.) or by electrophoresis at pH 2.0 and 3.5. Four radioactive peptides were separated by electrophoresis at pH 6.5 (Fig. 6a) , two of which, peptides 2C and 3C, contained 85% of the recovered radioactivity (35% of that applied to the gel-filtration column). The two other 32P-containing peptides, peptides IC and 4C, were obtained in low yields and could not be characterized. The amino acid composition of peptides 2C and 3C differed by the presence of a second arginine residue in peptide 2C (Table 2) .
In a previous study from this laboratory similar peptides were isolated after tryptic digestion of rabbit cardiac-muscle troponin I that had been incubated with [y-32P]ATP and 3': 5'-cyclic AMPdependent protein kinase . These peptides and those obtained in the present study were derived from the sequence Arg-Ser-AspArg-Ala-Tyr shown to be present in the N-terminal region of rabbit cardiac-muscle troponin I (Grand et al., 1976) . In view of the isolation of 32P-labelled phosphoserine after hydrolysis of 32P-labelled troponin I in 5.7 M-HCI (see above) the serine residue in peptides 2C and 3C, which corresponds to that at position-20 in the intact molecule, is presumed to be the residue phosphorylated. It was therefore concluded that the phosphate group on serine-20 was exchanging, presumably by enzymic reactions, with the phosphate pool of the control perfused heart.
Two other experiments were performed to locate the sites of phosphorylation of troponin I in the hearts not treated with adrenaline. In one case the 32P-labelled troponin I isolated by affinity chromatography was digested directly with trypsin, whereas in the other, the protein was digested with CNBr in 0.1 M-HCI and the peptide containing residues 1-48 subsequently digested with trypsin. In both experiments the only 32P-labelled peptides that could be identified contained serine-20. Identification of residues that are phosphorylated in the heart perfused in the presence ofadrenaline 32P-labelled troponin I isolated from rabbit hearts perfused in the presence of both 32P-labelled orthophosphate and adrenaline was digested with trypsin and the 32P-containing peptides were purified by gel CNBr peptides of troponin I prepared from the perfused rabbit heart Samples of troponin I prepared from perfused rabbit hearts were digested with CNBr and carboxymethylated with iodoacetic acid (Moir et al., 1974) . The digests were applied to a column (2. G-25 equilibrated and eluted with 50mM-NH4HCO3 (Fig. 5) followed by paper electrophoresis at pH 6.5 (Fig. 6b) , pH 2.0 and 3.5. The total recovery of radioactivity was 56%, of which 61% was associated with peptide 2A and 22% with peptide 3A (Table 2) . These peptides were identical with the radioactive peptides 2C and 3C isolated from the control perfused heart. Several other 32P-containing bands were located, but could not be characterized because of the very small amounts obtained. None were carboxymethylated (Moir et al., 1974 ) and applied to a column (2.5cm x 1Ocm) of Sephadex G-75 equilibrated and eluted with 0.01 M-HCI. Fractions (5 ml) were collected and the A215 was measured and radioactivity determined in alternate fractions by the Cerenkov procedure (Gould et al., 1972) . , A215; ----, radioactivity. (a) Troponin I prepared from control hearts; (b) troponin I prepared from hearts perfused in the presence of adrenaline (4pM). of these minor bands contained more than 5% of the recovered radioactivity. It was concluded that in the adrenaline-stimulated heart, as with the control per- . Gel filtration of enzymic digest of 32P-containing cardiac-muscle troponin I prepared from the perfused rabbit heart Samples of troponin I prepared from adrenalinestimulated rabbit hearts perfused with KrebsHenseleit buffer containing 32p were digested with trypsin and applied to a column (2.5 cm x 1 Ocm) of Sephadex G-25 equilibrated and eluted with 50mM-NH4HCO3. Fractions (5 ml) were collected and the A215 was measured and radioactivity in alternate fractions determined by the Cerenkov procedure.
,A 215; ----, 32P radioactivity. Pooled fractions of 32P-containing peptides obtained by gel filtration (Fig. 5) were further fractionated by paper electrophoresis at pH 6.5. Radioautograms were developed after exposure for approx. 40-60h.
(a), Peptides from control heart; (b), peptides from heart treated with adrenaline (4,UM). Abbreviation: 0, origin. fused hearts, virtually all of the 32p incorporated into the troponin I was located at serine-20.
Four other experiments were performed to study the incorporation of 32p into the adrenaline-treated perfused heart. In two experiments the 32P-containing troponin I was digested with trypsin, in another with trypsin and pepsin and in the fourth by CNBr in 0.1 M-HCI, followed by tryptic digestion of fragments containing residues 1-150 and 1-48 of the molecule. In all cases the only 32P-containing peptides that could be identified contained serine-20.
Estimation of the extent of phosphorylation of serine-20 in the perfused heart The experiments described above indicated that the amount of radioactivity at serine-20 increased when the heart perfused with 32P-labelled phosphate was treated with adrenaline. Despite the fact that the total covalently bound phosphate of troponin I clearly increases on adrenaline treatment, from the evidence provided so far it cannot be unequivocally concluded that this is due to an increase in phosphorylation at serine-20. The results from the studies with the CNBr peptides could be explained on the basis of increased exchange of phosphate with the intracellular pool. This might apply particularly if the increase in covalently bound phosphate of the intact troponin I due to adrenaline action took place on some other site that was relatively labile and lost during digestion with CNBr or enzymes. Direct determination of the phosphate content of the N-terminal CNBr peptide comprising residues Vol. 185 Table 3 . Phosphate contents ofN-terminal CNBrpeptidesfrom troponin I ofperfused rabbit heart Troponin I was isolated as indicated in Table 2 1-48 confirmed that a real increase in phosphate content had occurred (Table 3) .
Further evidence that a real increase in phosphorylation of serine-20 had occurred was obtained by analysis of the radiochemical data. Since the incorporation of 32p into troponin I in the perfused heart appears to be confined almost exclusively to one residue, it is possible to obtain an approximate value for the extent of phosphorylation of this residue in the control and adrenaline-treated hearts by comparing the specific radioactivity of the isolated protein to that of the small 32P-containing fragments isolated by paper electrophoresis. If the residue is completely phosphorylated, the specific radioactivity of the whole protein and of the fragment will-be similar; if phosphorylation is partial, the specific radioactivity of the small peptide will be higher than that of the whole protein (see .
It can be seen from Table 4 that in the control heart, the specific radioactivity of the isolated peptides was 3-fold higher than the activity of the intact protein, indicating incomplete phosphorylation of serine-20. In hearts treated with adrenaline, the specific radioactivities of the tryptic peptides were similar to that of the troponin I, demonstrating that the extent of phosphorylation of serine-20 approaches completion. 
Conclusions
The results indicate that in the normal perfused rabbit heart serine-20 of troponin I is about 30-40% phosphorylated and that phosphate on this site is exchanging with the phosphate pool, presumably in the form of ATP, of the myocardium. This phosphorylation site appears to be the only one that is in equilibration during the perfusion experiments with the intracellular phosphate pool. Phosphate at serine-20 appears to account for the total phosphate content of the N-terminal peptide consisting of residues 1-48 that is isolated after CNBr digestion and would in the normal perfused heart contribute 0.3-0.4 mol of phosphate/mol of troponin I. The fact that intact troponin I isolated from control perfused hearts contains a total of 1.15 mol of phosphate/mol suggests that other phosphorylation sites exist on the molecule. Nevertheless no significant amounts of phosphate could be detected in the CNBr peptides other than those containing residues 1-48. It seems likely that this discrepancy in phosphate content is due to the presence of a particularly labile site that is lost during the CNBr-digestion procedure. We have been unable so far to locate this site. As very little 32p was lost from labelled troponin I during CNBr digestion we conclude that the phosphate at serine-20 was stable to those conditions and furthermore that the labile site is not in dynamic equilibrium with the phosphate pool.
The increase in covalently bound phosphate of troponin I that occurs on perfusion with adrenaline is completely accounted for by the increase in phosphorylation at serine-20, the phosphate content of which changes from 0.3-0.4 to about 1.0mol of phosphate/mol when the rabbit heart is exposed to 4,uM-adrenaline in the perfusate. The increase in incorporation of 32p is due to the increased amount of phosphorylation at this site and as in the case of the control perfused heart is restricted to serine-20.
The studies in the perfused heart confirm the studies in vitro that showed serine-20 as the major site of phosphorylation when rabbit cardiac-muscle troponin I is incubated in vitro with cyclic AMPdependent protein kinase .
Thus it would appear that this increase in the extent of phosphorylation is due to the increased activity of 3':5'-cyclic AMP-dependent protein kinase in the perfused rabbit heart as a result of the administration of adrenaline.
Rabbit cardiac-muscle troponin I is also a substrate in vitro for phosphorylase b kinase (Cole & Perry, 1975) . Since the extent of phosphorylation of the phosphorylase kinase-specific sites of troponin I does not change in the perfused heart in response to adrenaline, it seems unlikely that the activity of this enzyme towards cardiac-muscle troponin I alters during the inotropic response. This supports the observation of England (1977) that phosphorylation of troponin I occurs in the perfused heart of phosphorylase kinase-deficient mice. The work of England (1976) with the rat and of this laboratory with the rabbit (C. Jones, R. J. Solaro & S. V. Perry, unpublished work) has demonstrated that the peak of the force increase in the perfused heart is reached before the phosphorylation of troponin I is maximal. Furthermore, phosphorylation of troponin I in cardiac-muscle natural actomyosin leads to a decrease in the sensitivity of the ATPase activity towards Ca2+ (Solaro et al., 1976; Ray & England, 1976; Reddy & Wyborny, 1976; Perry et al., 1978 Perry et al., , 1979 Bailin, 1979) . Thus the consequence of phosphorylation of cardiac-muscle troponin I at position-20 is not to increase directly the ATPase activity of the heart. Instead, the role of phosphorylation of troponin I is probably to smooth out the contractile response of the heart produced by the transient increase in Ca2+ concentrations that result from the administration of adrenaline or other fJ-adrenergic agents (Perry, 1979) . Thus phosphorylation of cardiac-muscle troponin I represents a negative-feedback control mechanism on the ATPase activity of the heart.
